SAND:OMXSTOSandvik AB Analysis
Data as of 2026-09-04 - not real-time
$1,554.99
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Sandisk Corporation is neutral at $1,554.99, with no clear ordering between short and long averages. It has lost 3.4% over the past 30 days. Momentum indicators put RSI at 52.6 (neutral) with MACD reading bullish. The recent range runs from support at $1,184.37 up to resistance at $1,827.99.
The shares look undervalued, trading on 21.1 times earnings below a sector average of 32.9. Sell-side targets cluster 36.7% above the current quote. Revenue is growing at 371.6% on a 56.5% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 127.6%, a beta of 4.27 and a maximum drawdown of 56.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
The shares look undervalued, trading on 21.1 times earnings below a sector average of 32.9. Sell-side targets cluster 36.7% above the current quote. Revenue is growing at 371.6% on a 56.5% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 127.6%, a beta of 4.27 and a maximum drawdown of 56.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 996.60
- MACD momentum is positive
- 30-day volatility of 127.6%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 21.1 versus sector average of 32.9
- Trading above the 200-day average of 996.60
- Analyst targets imply +36.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 21.1 versus sector average of 32.9
- Analyst targets imply +36.7% versus the current price
- Profit margin of 56.5% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth371.60%
Profit Margin56.46%
P/E Ratio21.1
ROE91.64%
ROA43.91%
Debt/Equity1.28
P/B Ratio14.7
Op. Cash Flow$11.7B
Free Cash Flow$7.7B
Industry P/E32.9
Technical Analysis
TrendNeutral
RSI52.6
Support$1,184.37
Resistance$1,827.99
MA 20$1,503.40
MA 50$1,562.15
MA 200$996.60
MACDBullish
VolumeDecreasing
Fear & Greed Index96.18
Valuation
Fair Value$1,845.26
Target Price$2,125.09
Upside/Downside36.66%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta4.27
Volatility127.60%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.